Extended single-dose toxicity study of [211At]meta-astatobenzylguanidine in normal mice in preparation for the first-in-human clinical trial of targeted alpha therapy for pheochromocytoma and paraganglioma

Related articles

1. Production of 211At and Automated Radiosynthesis of [211At]MABG via Electrophilic Astatodesilylation

   This article has 12 authors:

   1. Yuto Kondo
   2. Taiki Joho
   3. Shigenori Sasaki
   4. Kazumasa Mochizuki
   5. Naoko Hasegawa
   6. Naoyuki Ukon
   7. Ken-ichi Nishijima
   8. Kohshin Washiyama
   9. Hiroshi Tanaka
   10. Higashi Tatsuya
   11. Noriko S. Ishioka
   12. Kazuhiro Takahashi

2. Multifactorial Analysis of Radiochemical Purity in High-Activity 177Lu-Labeled Theranostics: Impact of Precursor Source, 177Lu Form, and Production Parameters

   This article has 10 authors:

   1. William Hunt
   2. Mathew Long
   3. Usama Kamil
   4. Sunil Kellapatha
   5. Wayne Noonan
   6. Peter D Roselt
   7. Nathan Papa
   8. Brittany Emmerson
   9. Michael S Hofman
   10. Mohammad B Haskali

3. Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: A single-arm, phase 2 clinical trial

   This article has 11 authors:

   1. Ting Han
   2. Meng Zhuo
   3. Xinyi Zheng
   4. Xiuqi Wu
   5. Feng Jiao
   6. Jiujie Cui
   7. Tao Wang
   8. Xiaoxia Qiu
   9. Yingjie Su
   10. Xiaolin Lin
   11. Xiuying Xiao